Featured Research

from universities, journals, and other organizations

Greater R&D funding needed to fight diseases affecting world's poor, experts say

Date:
June 21, 2011
Source:
Sabin Vaccine Institute
Summary:
Despite significant advancements in increasing distribution and development of vaccines against childhood killer diseases -- including pneumococcal disease, rotavirus, and Haemophilus influenzae type B -- global efforts to reduce the burden of infection from neglected tropical diseases have greatly lagged, argue experts.

Despite significant advancements in increasing distribution and development of vaccines against childhood killer diseases -- including pneumococcal disease, rotavirus, and Haemophilus influenzae Type B -- global efforts to reduce the burden of infection from neglected tropical diseases (NTDs) have greatly lagged, argues Sabin Vaccine Institute (Sabin) President Dr. Peter Hotez in an article for the June edition of Health Affairs.

NTDs, a group of 17 parasitic infections, represent a significant contributor to global poverty, and have well documented chronic and disabling effects. Yet efforts to develop vaccines for NTDs have not benefitted from larger ongoing initiatives to combat major childhood diseases.

In his article, "A Handful of 'Antipoverty' Vaccines Exist for Neglected Diseases, But the World's Poorest Billion People Need More," Dr. Hotez cites three critical reasons for the lack of interest in "antipoverty" vaccines:

  • Though NTDs disable, they do not typically cause high levels of mortality leading some in the public health community to misleadingly conclude that NTDs are not a significant public health threat;
  • NTDs predominately occur in rural settings and are largely hidden diseases unknown to the public and infrequently documented; and,
  • Pharmaceutical companies are reluctant to make an investment in NTD vaccines because there is no financial incentive.

Public-private partnerships increasingly represent an innovative mechanism for developing NTD vaccines, states Dr. Hotez in his article. In particular, manufacturers from middle-income countries are increasingly partnering with U.S. organizations and academic institutions to generate a pipeline of vaccines for NTDs. Sabin's vaccine development program -- currently developing vaccines for human hookworm infection and schistosomiasis -- represents one of a limited number of such partnerships.

Dr. Hotez concludes by stating that "developing a new generation of antipoverty vaccines represents a highly innovative and meaningful approach to eliminating the world's neglected diseases, lifting the bottom billion out of poverty, and promoting international diplomacy."

To expand its own vaccine development efforts, Sabin recently announced a new partnership with Texas Children's Hospital and Baylor College of Medicine (BCM) to build a new center in Houston dedicated to developing vaccines for diseases of poverty. Sabin will transfer its vaccine operations to new laboratories at Texas Children's Hospital in September and will continue working with existing and new partners.


Story Source:

The above story is based on materials provided by Sabin Vaccine Institute. Note: Materials may be edited for content and length.


Journal Reference:

  1. P. Hotez. A Handful Of 'Antipoverty' Vaccines Exist For Neglected Diseases, But The World's Poorest Billion People Need More. Health Affairs, 2011; 30 (6): 1080 DOI: 10.1377/hlthaff.2011.0317

Cite This Page:

Share This



More Health & Medicine News

Tuesday, September 16, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Man Floats for 31 Hours in Gulf Waters

Man Floats for 31 Hours in Gulf Waters

AP (Sep. 16, 2014) A Texas man is lucky to be alive after he and three others floated for more than a day in the Gulf of Mexico when their boat sank during a fishing trip. (Sept. 16) Video provided by AP
Powered by NewsLook.com
EU Ministers and Experts Meet to Discuss Ebola Reponse

EU Ministers and Experts Meet to Discuss Ebola Reponse

AFP (Sep. 15, 2014) The European Commission met on Monday to coordinate aid that the EU can offer to African countries affected by the Ebola outbreak. Duration: 00:58 Video provided by AFP
Powered by NewsLook.com
Despite The Risks, Antibiotics Still Overprescribed For Kids

Despite The Risks, Antibiotics Still Overprescribed For Kids

Newsy (Sep. 15, 2014) A new study finds children are prescribed antibiotics twice as often as is necessary. Video provided by Newsy
Powered by NewsLook.com
FDA Eyes Skin Shocks Used at Mass. School

FDA Eyes Skin Shocks Used at Mass. School

AP (Sep. 15, 2014) The FDA is considering whether to ban devices used by the Judge Rotenberg Educational Center in Canton, Massachusetts, the only place in the country known to use electrical skin shocks as aversive conditioning for aggressive patients. (Sept. 15) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins